PBSC mobilization in newly diagnosed patients with POEMS syndrome: outcomes and prognostic factors
PBSC mobilization in newly diagnosed patients with POEMS syndrome: outcomes and prognostic factors
复制标题
新诊断 POEMS 综合征患者的 PBSC 动员:结果和预后因素
DOI:
10.1038/bmt.2012.138
复制
发表时间:
2013
影响因子:
4.8
通讯作者:
D. Zhou
中科院分区:
文献类型:
--
作者:
Jian Li;Wei Zhang;Minghui Duan;L. Jiao;Tienan Zhu;Bing Han;Lu Zhang;J. Gan;D. Zhou
Autologous PBSC transplantation is a preferred treatment for patients with polyneuropathy, organomegaly, endocrinopathy, M protein, and skin changes (POEMS syndrome). However, data on stem cell mobilization in POEMS syndrome are limited. We retrospectively reviewed outcomes and factors prognostic of mobilization in newly diagnosed patients with POEMS syndrome. A total of 56 patients (41 men and 15 women) were included and the median age was 45 years (range, 24–62). All patients underwent mobilization with CY plus granulocyte CSF (G-CSF) (n=38) or G-CSF alone (n=18). The median total number of harvested CD34+ cells was 2.01 × 106/kg (range, 0.18–9.0 × 106/kg). In all, 29 (51.8%) patients failed to yield more than 2 × 106/kg CD34+ cells, and among them, 7 (12.5%) patients yielded <1 × 106/kg CD34+ cells. The overall mobilization-related morbidity was 23.3% and acute renal failure was the most common complication during mobilization. Multivariate analysis showed that hepatomegaly (odds ratio 0.06, 95% confidence interval (CI) 0.01–0.43) and mobilization regimen of G-CSF alone (odds ratio 0.08, 95% CI 0.01–0.70) were independent prognostic factors for successful mobilization in POEMS syndrome. In conclusion, mobilization in newly diagnosed patients with POEMS syndrome is challenging with low yield of CD34+ cells and high morbidity. Induction therapy before mobilization might improve the efficacy and safety of mobilization.
影响因子:
20.3
作者:
Dispenzieri, A;Kyle, RA;Gertz, MA
通讯作者:
Gertz, MA